Asia Pacific Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Rabies Vaccine Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $118.8 Million by 2030. The Japan market is registering a CAGR of 4.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.7% during (2023 - 2030).

Urbanization and encroachment into wildlife habitats can increase interactions between humans, domestic animals, and wildlife, raising the risk of dog bites. As urban areas expand and human populations grow, the potential for encountering rabies-infected animals, particularly dogs, escalates. This trend amplifies the importance of vaccination efforts to curb the spread of rabies.

There is a growing recognition of the interconnectedness of human, animal, and environmental health. The One Health approach emphasizes collaborative efforts between human and veterinary healthcare professionals, environmental scientists, and other stakeholders to address rabies at the interface of wildlife, domestic animals, and humans. This holistic perspective enhances the effectiveness of rabies control strategies by considering the complex interactions between different ecosystems.

India has a high incidence of rabies cases, and the disease is a serious public health issue. Public health awareness campaigns are crucial in educating communities about the risks of rabies and the importance of vaccination in India. Rabies control initiatives are implemented in rural and urban areas, recognizing that rabies affects populations across diverse settings in India. The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, is applied in rabies control efforts in India. As per a report published by the Ministry of Health and Family Welfare Government of India, dog-mediated rabies is responsible for an estimated 35172 human deaths (59.6% of global deaths) and 2.2 million disability-adjusted life years (DALYs) lost annually in Asia in 2022. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Free Valuable Insights: The Global Rabies Vaccine Market is Predict to reach USD 1.6 Billion by 2030, at a CAGR of 4.5%

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Limited
• Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Merck & Co., Inc.
• Novartis AG
• Bharat Biotech Ltd.
• Sanofi S.A.
• Virbac

Asia Pacific Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

• Post-exposure Prophylaxis
• Pre-exposure prophylaxis

By End User

• Hospitals
• Veterinary Clinics
• Others

By Application

• Human
• Animal

By Product Type

• Chick Embryo Cells Rabies Vaccine
• Human Diploid Cell Vaccine
• Vero cell rabies vaccine
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Rabies Vaccine Market, by Prophylaxis Type
1.4.2 Asia Pacific Rabies Vaccine Market, by End User
1.4.3 Asia Pacific Rabies Vaccine Market, by Application
1.4.4 Asia Pacific Rabies Vaccine Market, by Product Type
1.4.5 Asia Pacific Rabies Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Rabies Vaccine Market by Prophylaxis Type
4.1 Asia Pacific Post-exposure Prophylaxis Market by Country
4.2 Asia Pacific Pre-exposure prophylaxis Market by Country

Chapter 5. Asia Pacific Rabies Vaccine Market by End User
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Veterinary Clinics Market by Country
5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Rabies Vaccine Market by Application
6.1 Asia Pacific Human Market by Country
6.2 Asia Pacific Animal Market by Country

Chapter 7. Asia Pacific Rabies Vaccine Market by Product Type
7.1 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country
7.2 Asia Pacific Human Diploid Cell Vaccine Market by Country
7.3 Asia Pacific Vero Cell Rabies Vaccine Market by Country
7.4 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Rabies Vaccine Market by Country
8.1 China Rabies Vaccine Market
8.1.1 China Rabies Vaccine Market by Prophylaxis Type
8.1.2 China Rabies Vaccine Market by End User
8.1.3 China Rabies Vaccine Market by Application
8.1.4 China Rabies Vaccine Market by Product Type
8.2 Japan Rabies Vaccine Market
8.2.1 Japan Rabies Vaccine Market by Prophylaxis Type
8.2.2 Japan Rabies Vaccine Market by End User
8.2.3 Japan Rabies Vaccine Market by Application
8.2.4 Japan Rabies Vaccine Market by Product Type
8.3 India Rabies Vaccine Market
8.3.1 India Rabies Vaccine Market by Prophylaxis Type
8.3.2 India Rabies Vaccine Market by End User
8.3.3 India Rabies Vaccine Market by Application
8.3.4 India Rabies Vaccine Market by Product Type
8.4 South Korea Rabies Vaccine Market
8.4.1 South Korea Rabies Vaccine Market by Prophylaxis Type
8.4.2 South Korea Rabies Vaccine Market by End User
8.4.3 South Korea Rabies Vaccine Market by Application
8.4.4 South Korea Rabies Vaccine Market by Product Type
8.5 Singapore Rabies Vaccine Market
8.5.1 Singapore Rabies Vaccine Market by Prophylaxis Type
8.5.2 Singapore Rabies Vaccine Market by End User
8.5.3 Singapore Rabies Vaccine Market by Application
8.5.4 Singapore Rabies Vaccine Market by Product Type
8.6 Malaysia Rabies Vaccine Market
8.6.1 Malaysia Rabies Vaccine Market by Prophylaxis Type
8.6.2 Malaysia Rabies Vaccine Market by End User
8.6.3 Malaysia Rabies Vaccine Market by Application
8.6.4 Malaysia Rabies Vaccine Market by Product Type
8.7 Rest of Asia Pacific Rabies Vaccine Market
8.7.1 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type
8.7.2 Rest of Asia Pacific Rabies Vaccine Market by End User
8.7.3 Rest of Asia Pacific Rabies Vaccine Market by Application
8.7.4 Rest of Asia Pacific Rabies Vaccine Market by Product Type

Chapter 9. Company Profiles
9.1 Cadila Pharmaceuticals Limited
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.2 Bharat Biotech Ltd.
9.2.1 Company Overview
9.3 Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
9.3.1 Company Overview
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Elanco Animal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Zoetis, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Virbac
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 SWOT Analysis

TABLE 1 Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Human Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Human Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Animal Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Animal Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 33 Asia Pacific Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35 China Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36 China Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37 China Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38 China Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39 China Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40 China Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41 China Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42 China Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43 China Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44 China Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45 Japan Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46 Japan Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47 Japan Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48 Japan Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49 Japan Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50 Japan Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51 Japan Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52 Japan Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53 Japan Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54 Japan Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55 India Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56 India Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57 India Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58 India Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59 India Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60 India Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61 India Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62 India Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63 India Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64 India Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65 South Korea Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66 South Korea Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67 South Korea Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68 South Korea Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69 South Korea Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70 South Korea Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71 South Korea Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72 South Korea Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73 South Korea Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74 South Korea Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75 Singapore Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 76 Singapore Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 77 Singapore Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 78 Singapore Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 79 Singapore Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 80 Singapore Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 81 Singapore Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 82 Singapore Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 83 Singapore Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 84 Singapore Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 85 Malaysia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 86 Malaysia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 87 Malaysia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 88 Malaysia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 89 Malaysia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 90 Malaysia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 91 Malaysia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 92 Malaysia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 93 Malaysia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 94 Malaysia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 95 Rest of Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 96 Rest of Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 97 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 98 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 99 Rest of Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 100 Rest of Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 101 Rest of Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 102 Rest of Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 103 Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 104 Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 105 Key Information – Cadila Pharmaceuticals Limited
TABLE 106 Key Information – Bharat Biotech Ltd.
TABLE 107 Key Information – Serum Institute of India Pvt. Ltd.
TABLE 108 Key Information – Boehringer Ingelheim International GmbH
TABLE 109 Key information – Elanco Animal Health, Inc.
TABLE 110 Key Information – Zoetis, Inc.
TABLE 111 Key Information - Merck & Co., Inc.
TABLE 112 Key Information – Novartis AG
TABLE 113 Key Information – Sanofi S.A.
TABLE 114 Key Information – Virbac

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Rabies Vaccine Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Rabies Vaccine Market
FIG 4 Porter’s Five Forces Analysis – Rabies Vaccine Market
FIG 5 Asia Pacific Rabies Vaccine Market share by Prophylaxis Type, 2022
FIG 6 Asia Pacific Rabies Vaccine Market share by Prophylaxis Type, 2030
FIG 7 Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific Rabies Vaccine Market share by End User, 2022
FIG 9 Asia Pacific Rabies Vaccine Market share by End User, 2030
FIG 10 Asia Pacific Rabies Vaccine Market by End User, 2019 - 2030, USD Million
FIG 11 Asia Pacific Rabies Vaccine Market share by Application, 2022
FIG 12 Asia Pacific Rabies Vaccine Market share by Application, 2030
FIG 13 Asia Pacific Rabies Vaccine Market by Application, 2019 - 2030, USD Million
FIG 14 Asia Pacific Rabies Vaccine Market share by Product Type, 2022
FIG 15 Asia Pacific Rabies Vaccine Market share by Product Type, 2030
FIG 16 Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2030, USD Million
FIG 17 Asia Pacific Rabies Vaccine Market share by Country, 2022
FIG 18 Asia Pacific Rabies Vaccine Market share by Country, 2030
FIG 19 Asia Pacific Rabies Vaccine Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Elanco Animal Health, Inc.
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Novartis AG
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis: Virbac